Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2018

01-12-2018 | Correction

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

Authors: I. Blancas, M. Fontanillas, V. Conde, J. Lao, E. Martínez, M. J. Sotelo, A. Jaen, J. L. Bayo, F. Carabantes, J. J. Illarramendi, M. M. Gordon, J. Cruz, A. García-Palomo, C. Mendiola, E. Pérez-Ruiz, J. S. Bofill, J. M. Baena-Cañada, N. M. Jáñez, G. Esquerdo, M. Ruiz-Borrego

Published in: Clinical and Translational Oncology | Issue 12/2018

Login to get access

Excerpt

An information under Table 2 was published incorrectly. The correct data should read as follows: …
Metadata
Title
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Authors
I. Blancas
M. Fontanillas
V. Conde
J. Lao
E. Martínez
M. J. Sotelo
A. Jaen
J. L. Bayo
F. Carabantes
J. J. Illarramendi
M. M. Gordon
J. Cruz
A. García-Palomo
C. Mendiola
E. Pérez-Ruiz
J. S. Bofill
J. M. Baena-Cañada
N. M. Jáñez
G. Esquerdo
M. Ruiz-Borrego
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 12/2018
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-1956-7

Other articles of this Issue 12/2018

Clinical and Translational Oncology 12/2018 Go to the issue

Brief Research Article

Spanish National Oncological Research Center (CNIO): a bibliometric portrait

Research Article

Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer

Research Article

Radiolabeled F(ab′)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models

Research Article

Choice of antiepileptic drugs affects the outcome in cancer patients with seizures

Research Article

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

Correspondence

Letter to the Editor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits